Share this article
PORTLAND, Ore., May 25, 2021 /PRNewswire/ Allied Market Research recently published a report, titled, BFSI Crisis Management Market by Component (Solution and Services), Deployment Type (On-premises and Cloud), Enterprise Size (Large Enterprises and Small & Medium Enterprises (SMEs)), and Application (Disaster Recovery & Business Continuity, Risk & Compliance Management, Crisis Communication, Incident Management & Response, and Others), and End User (Banks, Insurance Companies, and Others): Global Opportunity Analysis and Industry Forecast, 2020–2027 . As per the report, the global BFSI crisis management industry was pegged at $8.46 billion in 2019, and is projected to reach $31.15 billion by 2027, growing at a CAGR of 18.2% from 2020 to 2027.
Drivers, restraints, and opportunities
BFSI Crisis Management Market to Reach $31 15 Bn, Globally, by 2027 at 18 2% CAGR: AMR
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
BFSI Crisis Management Market to Reach $31 15 Bn, Globally, by 2027 at 18 2% CAGR: AMR
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
gmmApril 28, 2021
The objective of the study is to define market sizes of different segments and countries in previous years and to forecast the values to the next Five years. The report is designed to incorporate both qualify qualitative and quantitative aspects of the industry with respect to each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as drivers and restraining factors which will define the future growth of the Oral Anti-Diabetic Drug market.
Anti-diabetic drug refers to the medications consumed orally that are prescribed to treat diabetes mellitus (type 2). It treats diabetes (type 2) by lowering down the blood sugar level. These are also known as oral hypoglycemic agents or oral antihyperglycemic agents. Oral anti-diabetic drugs are often prescribed as monotherapy but in severe cases, can be given in combination with insulin.